Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | XL092 |
Trade Name | |
Synonyms | XL-092|XL 092 |
Drug Descriptions |
XL092 is a receptor tyrosine kinase inhibitor that targets MET and other kinases and also prevents angiogenesis through inhibition of VEGF receptor subtypes (NCI Drug Dictionary). |
DrugClasses | MET Inhibitor 56 VEGFR Inhibitor (Pan) 33 |
CAS Registry Number | 2367004-54-2 |
NCIT ID | C161598 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + XL092 | Atezolizumab XL092 | 0 | 1 |
Ipilimumab + Nivolumab + XL092 | Ipilimumab Nivolumab XL092 | 0 | 1 |
Nivolumab + NKTR-214 + XL092 | NKTR-214 Nivolumab XL092 | 0 | 1 |
Nivolumab + XL092 | Nivolumab XL092 | 0 | 1 |
XL092 | XL092 | 0 | 2 |